tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS

Compare Aclaris Therapeutics (ACRS) vs. Competitors

Compare
883 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Aclaris Therapeutics
$3.54
$383.54M
-2.56
41.04%
3 Buy
0 Hold
0 Sell
Strong Buy
Inotiv
$0.54
$15.31M
-0.20
-90.10%
2 Buy
0 Hold
0 Sell
Moderate Buy
MDxHealth
$3.54
$175.22M
-5.56
87.30%
5 Buy
0 Hold
0 Sell
Strong Buy
Neuronetics
$1.55
$106.15M
-1.88
-55.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Exagen
$3.51
$79.55M
-3.79
-30.08%
5 Buy
0 Hold
0 Sell
Strong Buy
Sera Prognostics
$2.63
$101.50M
-3.42
-46.98%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACRS
Aclaris Therapeutics
3.54
0.97
37.74%
NOTV
Inotiv
0.45
-3.74
-89.35%
MDXH
MDxHealth
3.54
1.70
92.39%
STIM
Neuronetics
1.55
-1.72
-52.60%
XGN
Exagen
3.51
-1.82
-34.15%
SERA
Sera Prognostics
2.63
-2.41
-47.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts